Menu

CME Corner

Program Detail

Release Date: May-31-19
Credit Expiration Date: May-31-20

Faculty

Ray Dorsey, MD, MBA
David M. Levy Professor of Neurology
Director, Center for Health + Technology
University of Rochester
Rochester, NY

Marketa Marvanova, PharmD, PhD, BCGP, BCPP
Professor, Pharmacy Practice
Chair, Department of Pharmacy Practice
School of Pharmacy / College of Health Professions
North Dakota State University
Fargo, ND

Ann Kriebel-Gasparro, DrNP, MSN, CRNP, FNP-BC,GNP-BC
Walden University Clinical Instructor
MSN NP Program in the School of Nursing
President, Liberty Chapter of GAPNA
Philadelphia, PA

Credit Hours

ACCME: 1.0 AMA PRA Category 1 Credit
ACPE: 1.0 contact hour (0.10 CEU)
ANCC: 1.0 contact hour (which includes .5 hours of pharmacology credit)

Medium

Mobile + Online on Univadis

Program Description

Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance. Nonmotor symptoms include autonomic, olfactory, or cognitive dysfunction, as well as neuropsychiatric symptoms, including psychosis with hallucinations and delusions. Symptoms of PD can be more severe in people whose disease onset occurs at an older age. This multidisciplinary activity will examine evidence-based recommendations for the diagnosis and management of the motor and neuropsychiatric signs and symptoms of PD in older adults.

Program Developer/Facilitator


.

Target Audience

Physicians, advanced practice nurses, physician assistants, and consultant or senior care pharmacists who care for older adults.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Demonstrate increased knowledge and competence in diagnosis and staging of Parkinson’s disease.
  2. Develop individualized treatment plans that optimally manage symptoms, decrease motor fluctuations in OFF periods, reduce the incidence of dyskinesia, and maximize patient functionality and quality of life.

Nursing Learning Outcome: After attending this session, the learner will be able to outline optimal treatment and management of Parkinson’s disease.

Disclosures

Ray Dorsey, MD, MBA, discloses the following conflicts of interest.
Research support: AbbVie, Acadia, AMC Health, Biosensics, GlaxoSmithKline, Nuredis Pharmaceuticals, Pfizer, Prana Biotechnology, Raptor Pharmaceuticals, Roche, Teva
Consultant: 23andME, Abbot, AbbVie, American Well, Biogen, Clintrex, DeciBio, Denali Therapeutics, GlaxoSmithKline, Lundbeck, MC10, MedAvante, Mednick Associates, Olson Research Group, Optio, Origent Data Sciences, Inc., Prilenia, Putnam Associates, Sanofi, Shire, Sunovion Pharma, Teva, UCB, Voyager Therapeutics

Marketa Marvanova, PharmD, PhD, BCGP, BCPP, has no conflicts of interest to disclose.

Ann Kriebel-Gasparro, DrNP, MSN, CRNP, FNP-BC,GNP-BC, has no conflicts of interest to disclose.

Susan P. Tyler, MEd, CMP, CHCP, CME Director, University of Cincinnati, has no conflicts of interest to disclose.

Bruce C. Gebhardt, MD, CME Reviewer-Compliance, University of Cincinnati, has no conflicts of interest to disclose.

Heather Muskopf, Program Manager, Continuing Medical Education, University of Cincinnati, has no conflicts of interest to disclose.

Rosemarie Marmion, MSN, RN-BC, NE-BC, GAPNA Education Director, has no conflicts of interest to disclose.

Kathleen Hines, Vice President, Editorial Services, MCM Education, has no conflicts of interest to disclose.

The credit providers require all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

In this educational activity, the faculty reports that their presentation will not contain reference to investigational and/or off-label uses.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Credit Statements

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release date: May 31, 2019
Last review date: May 31, 2019
Expiration date: May 31, 2020

ACCME Accreditation Support:
Please contact the University of Cincinnati Continuing Medical Education Department at uccme@uc.edu or call 513-558-7277.

The American Society of Consultant Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity, ACPE UAN 0203-9999-19-035-H01-P is approved for 1.0 contact hour. Participants must view the activity in its entirety, complete the post-test (80% or higher) and evaluation to receive CPE credit. Initial Release Date: May 31, 2019, Expiration Date: May 31, 2020.

This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ), the Gerontological Advanced Practice Nurses Association (GAPNA), the University of Cincinnati, the American Society of Consultant Pharmacists, and MCM Education.

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.

Commercial Support Statements

This activity is supported by educational grants from Acorda and Neurocrine Biosciences.

Instructions

Completion Instructions

  1. Accessing Activity:
    * Click "Start Program" and log into program on QuantiaMD.com
    * Take the pre-test
    * Review the activity
    * Take the post-test and score 80%
    * You are allowed a total of 3 attempts
    * Complete the evaluation
    * View, print, or save a CME certificate verifying your
    credit/participation in this activity
  2. Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers

Certificate Fee

$0.00

There is no charge for CME/CPE/CNE credit.

Disclaimer

©2019. MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the University of Cincinnati, ASCP, GAPNA, Acorda, or Neurocrine Biosciences. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS